Thermo Fisher Scientific · 3 weeks ago
Corporate Development Senior Associate
Thermo Fisher Scientific is the world leader in serving science, enabling customers to make the world healthier, cleaner, and safer. The Corporate Development Senior Associate will play a key role in developing and executing inorganic growth strategies, providing competitive intelligence, and supporting M&A transactions across all business units.
BioinformaticsBiotechnologyCloud Data ServicesConsultingHealth CareLife ScienceManagement Information SystemsOffice SuppliesPrecision Medicine
Responsibilities
Support M&A strategy objectives including the development and tracking of acquisition opportunities and all phases of transaction execution
Participate on teams evaluating M&A opportunities and divestitures
Assist in the development and communication of the strategic case to obtain corporate leadership support for M&A initiatives
Build and present financial models including valuation and pro forma M&A analysis
Perform and lead due diligence processes
Support transaction execution
Facilitate the integration planning process as required
Perform industry and competitive research to support senior leaders
Analyze industry dynamics and the competitive landscape for valuation purposes
Analyze company SEC filings, Wall Street research, and market reports
Support special projects as assigned in connection with the Corporate Development team’s goals and strategy
Qualification
Required
Undergraduate degree preferably in Finance, Economics, Business Administration, science, or a technical field
4+ years of experience in M&A or Strategic Planning in the areas of acquisitions, divestitures, joint ventures and other investments, or equivalent experience at premier investment banking, consulting, or accounting firm. Alternately, an MBA with undergraduate degree, and a minimum of three years of previous corporate development/M&A experience
Excellent financial and analytical skills, including a solid understanding of valuation principles and fundamentals of financial statement analysis
Impeccable, exceptional attention to detail
Strong analytical and written / verbal communication skills including excellent, differentiated facility in Microsoft PowerPoint
Extensive experience using Microsoft Excel
Strong collaboration and project management skills
Excellent attitude and capacity for learning quickly in a very dynamic, intensive environment
Experience and demonstrated proficiency leading and prioritizing multiple projects
Ability to interact with senior executives and handle high pressure settings with confidence
Positive, enthusiastic attitude with capacity for learning quickly in an intensive and fast-paced environment
Benefits
Competitive remuneration
Annual incentive plan bonus scheme
Healthcare
401(k)
A range of employee benefits
A choice of national medical and dental plans, and a national vision plan, including health incentive programs
Employee assistance and family support programs, including commuter benefits and tuition reimbursement
At least 120 hours paid time off (PTO)
10 paid holidays annually
Paid parental leave (3 weeks for bonding and 8 weeks for caregiver leave)
Accident and life insurance
Short- and long-term disability in accordance with company policy
Retirement and savings programs, such as our competitive 401(k) U.S. retirement savings plan
Employees’ Stock Purchase Plan (ESPP) offers eligible colleagues the opportunity to purchase company stock at a discount
Company
Thermo Fisher Scientific
Thermo Fisher Scientific is a biotechnology and laboratory equipment company that provides a wide range of scientific products and services.
H1B Sponsorship
Thermo Fisher Scientific has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (272)
2024 (224)
2023 (233)
2022 (342)
2021 (315)
2020 (227)
Funding
Current Stage
Public CompanyTotal Funding
$15.97BKey Investors
National Grid
2025-11-24Post Ipo Debt· $2.42B
2025-09-30Post Ipo Debt· $2.5B
2023-08-07Post Ipo Debt· $2.95B
Leadership Team
Recent News
2026-01-09
EIN Presswire
2026-01-07
Company data provided by crunchbase